{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:06:17Z","timestamp":1785391577239,"version":"3.55.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aim of this study was to examine the effects of formulations of polysorbate 80 (PS 80) and polyethylene glycol 400 (PEG 400) on the precipitation and oral bioavailability of the hydrophobic drug halofantrine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The in-vitro dilution profile of the formulations was evaluated in phosphate buffer and in simulated intestinal fluids using a standard dissolution apparatus. The pharmacokinetic profile of the formulations was investigated in fasted rats at two dose levels, 5 and 17.5 mg\/kg, with blood sampling by vein puncture in the tail.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>The solubility of halofantrine was found to be highest in PS 80, and in co-mixtures there was a correlation with the content of PS 80. The in-vitro dilution profile revealed precipitation of halofantrine when dissolved in pure PEG 400, although the precipitation was smaller in the simulated intestinal fluid. Addition of 25% PS 80 to the PEG 400 significantly decreased precipitation. The animals dosed with the PEG 400 formulation had significant lower bioavailability than the PS 80\u2013PEG 400 co-mixtures, possibly due to halofantrine precipitation in the gastrointestinal tract.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Addition of PS80 to the formulation increased the bioavailability of halofantrine and the more compound, the more PS80 was needed to prevent precipitation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1211\/jpp.62.01.0006","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T12:05:53Z","timestamp":1287057953000},"page":"63-70","source":"Crossref","is-referenced-by-count":24,"title":["Effects of polysorbate 80 on the in-vitro precipitation and oral bioavailability of halofantrine from polyethylene glycol 400 formulations in rats"],"prefix":"10.1093","volume":"62","author":[{"given":"Henrik","family":"T\u00f8nsberg","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics and Analytical Chemistry, University of Copenhagen ,","place":["Denmark"]},{"name":"Preformulation, H. Lundbeck A\/S , Valby,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Holm","sequence":"additional","affiliation":[{"name":"Preformulation, H. Lundbeck A\/S , Valby,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Bisgaard","sequence":"additional","affiliation":[{"name":"Preformulation, H. Lundbeck A\/S , Valby,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Jacobsen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Analytical Chemistry, University of Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"M\u00fcllertz","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Analytical Chemistry, University of Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,1,1]]},"reference":[{"key":"2024103013102368600_cit1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopha.2004.02.001","article-title":"Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs","volume":"58","author":"Gursoy","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"2024103013102368600_cit2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.addr.2007.05.006","article-title":"Oral lipid-based formulations","volume":"59","author":"Hauss","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"2024103013102368600_cit3","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/jps.20886","article-title":"Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME)","volume":"96","author":"Dai","year":"2006","journal-title":"J Pharm Sci"},{"key":"2024103013102368600_cit4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2008.07.003","article-title":"Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80","volume":"35","author":"Lind","year":"2008","journal-title":"Eur J Pharm Sci"},{"key":"2024103013102368600_cit5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat Rev Drug Disc"},{"key":"2024103013102368600_cit6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0278-6915(94)00119-9","article-title":"Effects of polyethylene-glycol-400 (PEG-400) following 13 weeks of gavage treatment in Fischer-344 Rats","volume":"33","author":"Hermansky","year":"1995","journal-title":"Food Chem Toxicol"},{"key":"2024103013102368600_cit7","first-page":"566","article-title":"Acute intravenous toxicity of dimethyl-sulfoxide, polyethylene-glycol-400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains","volume":"1","author":"Montaguti","year":"1994","journal-title":"Arzm Forsch-Drug Res"},{"key":"2024103013102368600_cit8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/1520-6017(200007)89:7<946::AID-JPS12>3.0.CO;2-2","article-title":"Study of phase behavior of poly(ethylene glycol)-polysorbate 80 and poly(ethylene glycol)-polysorbate 80-water mixtures","volume":"89","author":"Tejwani","year":"2000","journal-title":"J Pharm Sci"},{"key":"2024103013102368600_cit9","volume-title":"Handbook of pharmaceutical excipients","author":"Rowe","year":"2006","edition":"5th"},{"key":"2024103013102368600_cit10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejps.2007.06.008","article-title":"Development and validation of in silico models for estimating drug preformulation risk in PEG400\/water and Tween80\/water systems","volume":"32","author":"Crivori","year":"2007","journal-title":"Eur J Pharm Sci"},{"key":"2024103013102368600_cit11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jps.2600720911","article-title":"In vitro method for detecting precipitation of parenteral formulations after injection","volume":"72","author":"Yalkowsky","year":"1983","journal-title":"J Pharm Sci"},{"key":"2024103013102368600_cit12","first-page":"417","article-title":"Precipitation of solubilized drugs due to injection or dilution","volume":"11","author":"Yalkowsky","year":"1977","journal-title":"Drug Intell Clin Pharm"},{"key":"2024103013102368600_cit13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1517\/17425255.2.5.715","article-title":"Preclinical formulations for discovery and toxicology: physicochemical challenges","volume":"2","author":"Neervannan","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2024103013102368600_cit14","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s11095-008-9641-0","article-title":"Lipid-based formulations for Danazol containing a digestible surfactant, Labrafil M 2125CS: in vivo bioavailability and dynamic in vitro lipolysis","volume":"25","author":"Larsen","year":"2008","journal-title":"Pharm Res"},{"key":"2024103013102368600_cit15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.2042-7158.1991.tb06697.x","article-title":"Intestinal absorption of drugs. The influence of mixed micelles on the disappearance kinetics of drugs from the small intestine of the rat","volume":"43","author":"Poelma","year":"1991","journal-title":"J Pharm Pharmacol"},{"key":"2024103013102368600_cit16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/js960483y","article-title":"Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells","volume":"86","author":"Nerurkar","year":"1997","journal-title":"J Pharm Sci"},{"key":"2024103013102368600_cit17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.05.049","article-title":"Developing early formulations: practice and perspective","volume":"341","author":"Li","year":"2007","journal-title":"Int J Pharm"},{"key":"2024103013102368600_cit18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jps.2600821126","article-title":"Correction factor for dissolution profile calculations","volume":"82","author":"Aronson","year":"1993","journal-title":"J Pharm Sci"},{"key":"2024103013102368600_cit19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0731-7085(95)01256-K","article-title":"A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions","volume":"13","author":"Humberstone","year":"1995","journal-title":"J Pharm Biomed Anal"},{"key":"2024103013102368600_cit20","volume-title":"Clinical pharmacokinetics: concepts and applications","author":"Rowland","year":"1995","edition":"1st"},{"key":"2024103013102368600_cit21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/js950472p","article-title":"A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine","volume":"85","author":"Humberstone","year":"1996","journal-title":"J Pharm Sci"},{"key":"2024103013102368600_cit22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm Drug Dispos"},{"key":"2024103013102368600_cit23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1081\/DDC-120028718","article-title":"Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturable formulations","volume":"30","author":"Gao","year":"2004","journal-title":"Drug Dev Ind Pharm"},{"key":"2024103013102368600_cit24","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1023\/A:1010927026837","article-title":"The effect of polyethylene glycol 400 on gastrointestinal transit: implications for the formulation of poorly water-soluble drugs","volume":"18","author":"Basit","year":"2001","journal-title":"Pharm Res"},{"key":"2024103013102368600_cit25","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1023\/A:1020315228237","article-title":"Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine","volume":"19","author":"Basit","year":"2002","journal-title":"Pharm Res"},{"key":"2024103013102368600_cit26","first-page":"646","article-title":"The influence of formulation on the absorption of orally administered griseofulvin preparations in rabbits","volume":"42","author":"Hansford","year":"1980","journal-title":"Pharm Ind"},{"key":"2024103013102368600_cit27","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/jps.10511","article-title":"Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability","volume":"92","author":"Gao","year":"2003","journal-title":"J Pharm Sci"},{"key":"2024103013102368600_cit28","first-page":"48","article-title":"Toxicologic, pharmacodynamic and clinical observations on Tween 80","volume":"97","author":"Krantz","year":"1949","journal-title":"Bull Sch Med Univ"},{"key":"2024103013102368600_cit29","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1007\/s11095-004-7684-4","article-title":"Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and a cannulated rat intestinal lymphatic model","volume":"21","author":"Seeballuck","year":"2004","journal-title":"Pharm Res"},{"key":"2024103013102368600_cit30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1113\/jphysiol.1977.sp011991","article-title":"Action of oleic acid on the exocrine pancreatic secretion of the conscious rat: evidence for an anti-cholecystokinin-pancreozymin factor","volume":"271","author":"Laugier","year":"1977","journal-title":"J Physiol"},{"key":"2024103013102368600_cit31","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/gut.31.10.1126","article-title":"Characteristics of lipid substances activating the ileal brake in the rat","volume":"31","author":"Brown","year":"1990","journal-title":"Gut"},{"key":"2024103013102368600_cit32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1023\/A:1018827030210","article-title":"The effect of oleic acid on the human ileal brake and its implications for small intestinal transit of tablet formulations","volume":"16","author":"Dobson","year":"1999","journal-title":"Pharm Res"},{"key":"2024103013102368600_cit33","first-page":"653","article-title":"Modificazioni della coleresi nel ratto con alcuni solventi e disperdenti usati come veicoli de farmaci","volume":"49","author":"Croce","year":"1973","journal-title":"Boll Soc Ital Biol Sper"},{"key":"2024103013102368600_cit34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0928-0987(01)00186-5","article-title":"Comparison of the lymphatic transport of halofantrine from 3 different unsaturated triglycerides in lymph-cannulated conscious rats","volume":"14","author":"Holm","year":"2001","journal-title":"Eur J Pharm Sci"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2Fjpp.62.01.0006","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/62\/1\/63\/60233710\/jpp.62.01.0006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/62\/1\/63\/60233710\/jpp.62.01.0006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T18:46:11Z","timestamp":1730313971000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/62\/1\/63\/6135738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1,1]]},"published-print":{"date-parts":[[2010,1,1]]}},"URL":"https:\/\/doi.org\/10.1211\/jpp.62.01.0006","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,1]]},"published":{"date-parts":[[2010,1,1]]}}}